Skip to main content
. 2017 Mar 15;37(5):2711–2719. doi: 10.3892/or.2017.5506

Figure 2.

Figure 2.

miR-200a inhibits the release of MVs from HepG2 and Huh7 cells. (A) hsa-miR-200a expression level of 48 HCC tissues from TCGA database was significantly lower compared with corresponding non-tumor normal tissues. P<0.0001. (B) miR-200a expression level was downregulated in HepG2 and Huh7 cells compared with HL7702 cells, while miR-483 was upregulated. (C) miR-200a suppressed the release of MVs derived from HepG2 and Huh7 cells by flow cytometry. (D) Statistical analysis of MV release. miR-200a inhibited the MV release from HepG2 and Huh7 cells. *P<0.05.